Last Posted: Apr 11, 2019
- Public Willingness to Undergo Presymptomatic Genetic Testing for Alzheimer's Disease.
Alanazy Mohammed H et al. Neurology research international 2019 20192570513 - The Alzheimer's comorbidity phenome: mining from a large patient database and phenome-driven genetics prediction.
Zheng Chunlei et al. JAMIA open 2019 Apr 2(1) 131-138 - APOE genotype influences the gut microbiome structure and function in humans and mice: relevance for Alzheimer's disease pathophysiology.
Tran Tam T T et al. FASEB journal : official publication of the Federation of American Societies for Experimental Biology 2019 Apr fj201900071R - Analysis of 50 Neurodegenerative Genes in Clinically Diagnosed Early-Onset Alzheimer's Disease.
Giau Vo Van et al. International journal of molecular sciences 2019 Mar 20(6) - Another major drug candidate targeting the brain plaques of Alzheimer’s disease has failed. What’s left?
K Servick, Science, March 21, 2019 - Dementia risk prediction models - what do policymakers need to know
PHG Foundation, March 19, 2019 - Newly discovered Alzheimer's genes further hope for future treatments
S Lamotte, CNN, March 3, 2019 - Gene Therapy for APOE4 Homozygote of Alzheimer's Disease
NIH Clinical Trials, 2019 - Doctors plan to test a gene therapy that could prevent Alzheimer’s disease
A Regalado, MIT Tech Review, February 25, 2019 - GeneMatch: A novel recruitment registry using at-home APOE genotyping to enhance referrals to Alzheimer's prevention studies.
Langbaum Jessica B et al. Alzheimer's & dementia : the journal of the Alzheimer's Association 2019 Feb
.png)
No hay comentarios:
Publicar un comentario